Ipilimumab plus sargramostim vs ipilimumab alone for treatment of metastatic melanoma: a randomized clinical trial (Q30407940)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Ipilimumab plus sargramostim vs ipilimumab alone for treatment of metastatic melanoma: a randomized clinical trial |
scientific article |
Statements
Ipilimumab plus sargramostim vs ipilimumab alone for treatment of metastatic melanoma: a randomized clinical trial (English)
Sandra Lee
David F McDermott
Uma N Rao
Ahmad A Tarhini
Philip Leming
Donghoon Shin
John M Kirkwood
1 November 2014
1 reference
1 reference
1 reference
1 reference